SK bioscienceLtd Balance Sheet Health
Financial Health criteria checks 4/6
SK bioscienceLtd has a total shareholder equity of ₩1,691.5B and total debt of ₩80.0B, which brings its debt-to-equity ratio to 4.7%. Its total assets and total liabilities are ₩1,918.1B and ₩226.5B respectively.
Key information
4.7%
Debt to equity ratio
₩80.00b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩1.25t |
| Equity | ₩1.69t |
| Total liabilities | ₩226.52b |
| Total assets | ₩1.92t |
Financial Position Analysis
Short Term Liabilities: A302440's short term assets (₩1,386.6B) exceed its short term liabilities (₩134.1B).
Long Term Liabilities: A302440's short term assets (₩1,386.6B) exceed its long term liabilities (₩92.4B).
Debt to Equity History and Analysis
Debt Level: A302440 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A302440's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A302440's debt is well covered by operating cash flow (89.1%).
Interest Coverage: Insufficient data to determine if A302440's interest payments on its debt are well covered by EBIT.